Kolmar BNH Co., Ltd. (200130.KQ)
KRW 13840.0
(1.84%)
KRW 13840.0
(1.84%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 579.55 Billion KRW | 0.63% |
| 2022 | 575.9 Billion KRW | -2.9% |
| 2021 | 593.08 Billion KRW | -2.28% |
| 2020 | 606.89 Billion KRW | 38.27% |
| 2019 | 438.9 Billion KRW | 13.6% |
| 2018 | 386.36 Billion KRW | 14.46% |
| 2017 | 337.56 Billion KRW | 31.86% |
| 2016 | 256 Billion KRW | 8.39% |
| 2015 | 236.18 Billion KRW | 0.0% |
| 2014 | - KRW | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 165.91 Billion KRW | 3.55% |
| 2024 Q1 | 160.22 Billion KRW | 9.98% |
| 2023 FY | 579.55 Billion KRW | 0.63% |
| 2023 Q1 | 137.71 Billion KRW | 0.83% |
| 2023 Q2 | 156.79 Billion KRW | 13.86% |
| 2023 Q3 | 139.37 Billion KRW | -11.11% |
| 2023 Q4 | 145.68 Billion KRW | 4.53% |
| 2022 FY | 575.9 Billion KRW | -2.9% |
| 2022 Q4 | 136.57 Billion KRW | 4.04% |
| 2022 Q3 | 131.27 Billion KRW | -21.46% |
| 2022 Q2 | 167.14 Billion KRW | 18.63% |
| 2022 Q1 | 140.89 Billion KRW | -2.24% |
| 2021 Q2 | 146.54 Billion KRW | -15.67% |
| 2021 Q3 | 128.64 Billion KRW | -12.22% |
| 2021 FY | 593.08 Billion KRW | -2.28% |
| 2021 Q1 | 173.77 Billion KRW | 10.65% |
| 2021 Q4 | 144.12 Billion KRW | 12.03% |
| 2020 FY | 606.89 Billion KRW | 38.27% |
| 2020 Q4 | 157.05 Billion KRW | 7.36% |
| 2020 Q3 | 146.28 Billion KRW | -16.13% |
| 2020 Q2 | 174.41 Billion KRW | 35.05% |
| 2020 Q1 | 129.14 Billion KRW | 19.86% |
| 2019 Q2 | 116.42 Billion KRW | 9.23% |
| 2019 Q1 | 106.57 Billion KRW | -2.52% |
| 2019 FY | 438.9 Billion KRW | 13.6% |
| 2019 Q4 | 107.74 Billion KRW | -0.38% |
| 2019 Q3 | 108.15 Billion KRW | -7.1% |
| 2018 Q2 | 90.92 Billion KRW | -5.91% |
| 2018 Q1 | 96.63 Billion KRW | 171.64% |
| 2018 Q3 | 89.47 Billion KRW | -1.6% |
| 2018 FY | 386.36 Billion KRW | 14.46% |
| 2018 Q4 | 109.33 Billion KRW | 22.2% |
| 2017 FY | 337.56 Billion KRW | 31.86% |
| 2017 Q2 | 110.63 Billion KRW | 57.78% |
| 2017 Q1 | 70.11 Billion KRW | 7.05% |
| 2017 Q4 | 35.57 Billion KRW | -70.66% |
| 2017 Q3 | 121.24 Billion KRW | 9.59% |
| 2016 Q2 | 67.81 Billion KRW | 6.76% |
| 2016 FY | 256 Billion KRW | 8.39% |
| 2016 Q4 | 65.5 Billion KRW | 10.69% |
| 2016 Q3 | 59.17 Billion KRW | -12.74% |
| 2016 Q1 | 63.51 Billion KRW | 12.58% |
| 2015 Q4 | 56.41 Billion KRW | -7.25% |
| 2015 Q3 | 60.82 Billion KRW | -5.11% |
| 2015 Q2 | 64.1 Billion KRW | 16.92% |
| 2015 Q1 | 54.83 Billion KRW | 0.0% |
| 2015 FY | 236.18 Billion KRW | 0.0% |
| 2014 FY | - KRW | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| NeoPharm CO., LTD. | 97.1 Billion KRW | -496.83% |